Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101415476 | 10141547 | 6 | F | 201404 | 20160918 | 20140429 | 20160921 | EXP | US-GLAXOSMITHKLINE-A1071256A | GLAXOSMITHKLINE | 64.07 | YR | F | Y | 0.00000 | 20160921 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101415476 | 10141547 | 1 | PS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 26 NG/KG/MIN CONTINUOUS, CONCENTRATION: 45,000 NG/ML, PUMP RATE: 82 ML/DAY, VIAL STRENGTH: 1.5 MG). | D | R614 | 20444 | 26 | DF | POWDER FOR INFUSION | |||||
| 101415476 | 10141547 | 2 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | D | S276 | 20444 | POWDER FOR INFUSION | ||||||||
| 101415476 | 10141547 | 3 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 26 DF (CONCENTRATION 45,000 NG/ML, PUMP RATE 82 ML/DAY, VIAL STRENGTH 1.5 MG), CO | D | V926 | 20444 | 26 | DF | POWDER FOR INFUSION | |||||
| 101415476 | 10141547 | 4 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 26 NG/KG/MIN CONTINUOUS | D | Z880 | 20444 | 26 | DF | POWDER FOR INFUSION | |||||
| 101415476 | 10141547 | 5 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | D | C764454 | 0 | SOLUTION FOR INJECTION | ||||||||
| 101415476 | 10141547 | 6 | C | COUMADIN | WARFARIN SODIUM | 1 | U | 0 | |||||||||||
| 101415476 | 10141547 | 7 | C | REVATIO | SILDENAFIL CITRATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101415476 | 10141547 | 1 | Pulmonary arterial hypertension |
| 101415476 | 10141547 | 5 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101415476 | 10141547 | DE |
| 101415476 | 10141547 | HO |
| 101415476 | 10141547 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101415476 | 10141547 | Cardiac disorder | |
| 101415476 | 10141547 | Catheter removal | |
| 101415476 | 10141547 | Central venous catheterisation | |
| 101415476 | 10141547 | Device breakage | |
| 101415476 | 10141547 | Dialysis related complication | |
| 101415476 | 10141547 | Dyspnoea | |
| 101415476 | 10141547 | Hospitalisation | |
| 101415476 | 10141547 | Renal disorder | |
| 101415476 | 10141547 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 101415476 | 10141547 | 1 | 20030513 | 0 | ||
| 101415476 | 10141547 | 2 | 20030513 | 0 | ||
| 101415476 | 10141547 | 4 | 20070103 | 0 | ||
| 101415476 | 10141547 | 5 | 20070103 | 0 |